A Risk Assessment Tool to Increase Statin Use Among High Risk Cancer Survivors: Development and Pilot Testing

CompletedOBSERVATIONAL
Enrollment

49

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

June 11, 2020

Study Completion Date

June 11, 2020

Conditions
Cancer SurvivorsStatin Use Among High Risk Survivors
Interventions
BEHAVIORAL

usual care

In order to characterize the content of and variation in usual care, the first 25 patients enrolled in the study will complete a post-visit questionnaire that asks what their doctor told them (if anything) about their risk of cardiovascular disease, risk reduction and statins specifically, and how this information was presented

BEHAVIORAL

statin communication tool

The Statin Choice decision aid uses icon arrays to communicate the expected benefits of statins. This modified risk communication tool will maintain the components of the validated original. The adapted paper-based risk communication tool will describe modified risk profiles applicable to the survivors at increased risk for cardiac disease due to chest irradiation.

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT02895880 - A Risk Assessment Tool to Increase Statin Use Among High Risk Cancer Survivors: Development and Pilot Testing | Biotech Hunter | Biotech Hunter